Background Image
Table of Contents Table of Contents
Previous Page  31 / 60 Next Page
Information
Show Menu
Previous Page 31 / 60 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 32, No 2, March/April 2021

AFRICA

85

mechanism with SARS-COV because the two viruses are highly

homologous in the genome.

13,14

In our study, plasma TnT levels were significantly positively

correlated with other plasma inflammatory markers such as

fibrinogen, D-dimer, ferritin, procalcitonin and CRP, indicating

that myocardial injury may be closely related to inflammatory

pathogenesis during the evolution of the disease.

Viral particles could precipitate a cytokine storm and a

series of immune responses. Huang

et al

.

4

emphasised that

in patients with COVID-19, an imbalance of T-helper 1 and

T-helper 2 responses developed in a cytokine storm, which

may have contributed to myocardial injury. The release of

inflammatory cytokines after infection may cause a reduction in

coronary blood flow, decrease in oxygen supply, destabilisation

of coronary plaque and microcirculatory thrombogenesis.

Unpredictably, the proportion of smokers was statistically

significantly lower in patients with myocardial injury than in

those without injury (

p

<

0.01) (Table 1).

In a recently published article, Guo

et al

.

15

found 11 of 18

patients who were in the smoking group had normal TnT levels

and seven had elevated troponin levels. However, it was not

statistically significant. In another trial, researchers found no link

between cigarette smoking and the severity of COVID-19 among

cases in China, according to results of a preliminary meta-

analysis published in the

European Journal of Internal Medicine

.

16

Although there are articles showing no relationship between

smoking and the severity of COVID-19, there are also articles

showing the opposite. Therefore, this situation remains uncertain

and more studies are needed to clarify it.

Study limitations

First, as a retrospective study, information regarding cardiovascular

complications, such as from echocardiography, and other

inflammatory markers, such as cytokine levels, including IL-6, are

not presented in this study because the data were incomplete owing

2 000.00

1 800.00

1 600.50

1 400.00

1 200.50

1 000.00

1.00 2.00 3.00

Thorax CT

Mean of D-dimer,

μ

g/l

Thorax CT: 1 (mild pneumonia), 2 (moderate pneumonia), 3 (severe pneumonia)

900.00

800.00

700.00

600.00

500.00

400.00

1.00 2.00 3.00

Thorax CT

Mean of ferritin, ng/ml

600.00

500.00

560.00

540.00

520.00

500.00

1.00 2.00 3.00

Thorax CT

Mean of fibrinogen, mg/dl

Fig. 4.

Mean plots of serum levels of ferritin, D-dimer and fibrinogen compared with patients grouped according to thorax CT scans,

which were divided into three categories: 1, mild pneumonia; 2, moderate pneumonia; and 3, severe pneumonia.